HC SURGICAL SPECIALISTS LIMITED
(Incorporated in the Republic of Singapore) (Company Registration No. 201533429G)
FY2025 Sustainability ReportThis Sustainability Report has been reviewed by the Company's sponsor, Novus Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this Sustainability Report, including the correctness of any of the statements or opinions made, or reports contained in this Sustainability Report.
The contact person for the Sponsor is Mr. Pong Chen Yih, Chief Operating Officer, at 7 Temasek Boulevard, #04-02 Suntec Tower 1, Singapore 038987, telephone (65) 6950 2188.
Contents
BOARD STATEMENT 2
ABOUT THIS REPORT 3
ABOUT THE GROUP 4
OUR SUSTAINABILITY APPROACH 6 OUR STAKEHOLDERS 7 MATERIALITY ASSESSMENT 8 PATIENTS' PRIVACY 9 EMPLOYMENT 10 ECONOMIC PERFORMANCE 13 TCFD REPORT 15 GRI CONTENT INDEX 23 TCFD CONTENT INDEX 25BOARD STATEMENT
Dear Stakeholders,On behalf of the Board of Directors and Management of HC Surgical Specialists Limited ("HCSS"), I am pleased to present our eighth annual Sustainability Report for the financial year ended 31 May 2025 ("FY2025"). This report reinforces our unwavering dedication to embedding environmental, social, and governance ("ESG") principles across all facets of our operations.
Our Board of Directors prioritises sustainability as a fundamental component of our business strategy, ensuring long-term value creation for our stakeholders through robust governance, environmental responsibility, and social accountability. The Board actively considered sustainability issues in shaping our business strategy, identifying material ESG factors, and monitoring their effective management.
In FY2025, we focused on aligning our business practices with long-term strategic goals and stakeholder expectations, maintaining a strong emphasis on sustainability. The Board collaborated closely with senior management to identify and manage key ESG factors that could significantly impact our business. We achieved notable progress in our sustainability practices, particularly in the protection of patients' privacy.
Looking ahead, we will continue to integrate sustainability into our core business operations, promoting environmental stewardship, workplace inclusivity, and responsible governance. These endeavours drive our efforts to enhance patient care and positively impact our community and the environment.
We extend our sincere gratitude for the continued support of our stakeholders. Through our collective efforts, we are committed to building a sustainable future, enhancing lives, and creating a thriving environment for generations to come.
Mr. Chong Weng Hoe Non-Executive Chairman and Independent DirectorABOUT THIS REPORT
This Sustainability Report, covering the financial year starting 1 June 2024 and ended 31 May 2025, provides a detailed account of our progress on key sustainability initiatives. It is prepared in accordance with Rules 711A and 711B of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist (the "Catalist Rules") and also adheres to Practice Note 7F Sustainability Reporting Guide of the Catalist Rules.
Reporting Framework
This Report has been prepared with reference to the Global Reporting Initiative ("GRI") Standards 2021, which we have selected as our preferred framework due to its international recognition, wide adoption, and alignment with our business model. We have applied all GRI reporting principles, including accuracy, balance, clarity, comparability, completeness, sustainability context, timeliness, and verifiability in the preparation of this Report. Going forward, we will also incorporate the climate-related requirements in International Sustainability Standards Board's ("ISSB") IFRS Sustainability Disclosure Standards ("IFRS SDS") for climate-related financial information on a phased approach.
External Assurance
To ensure the accuracy of the data and information presented, we have relied on internal verification and engaged internal auditors to review our sustainability reporting processes. We may, in the future, seek external independent assurance to further strengthen our sustainability reporting practices.
Hardcopies of the Sustainability Report will be mailed to shareholders upon request. The electronic version of the report can be found on our website at https://www.hcsurgicalspecialists.com/ as well as SGXNet, at https://www.sgx.com/securities/company-announcements.
Feedback
We value the input of our stakeholders and invite you to share your feedback and suggestions regarding the contents of this Report at contact@hcsurgicalspecialists.com.
ABOUT THE GROUP
HC Surgical Specialists Limited ("HCSS" and its subsidiaries, collectively the "Group"), is a medical services group that offers a range of endoscopic procedures, including gastroscopies and colonoscopies, alongside general surgery services. The Group specialises particularly in colorectal procedures and operates a network of 18 clinics strategically located throughout Singapore.
Since its inception nearly a decade ago, HCSS has been committed to providing accessible private healthcare to a broad patient base. The Group's clinics, conveniently situated near public transportation, offer a spectrum of services, including endoscopy clinics accredited by MediSave and MediShield Life. The successful integration of orthopaedics services and the expansion of our clinic locations have enabled us to better serve the local community and extend our physical presence. We remain dedicated to maintaining and further expanding our network of clinics to more effectively serve our patients.
Our Group's medical clinics and facilities are as follows:
As a public company limited by shares, our registered office is located at 9 Raffles Place, #26-01 Republic Plaza, Singapore 048619.